Multiple Sclerosis News

The latest multiple sclerosis stories, summarized by AI

"Unveiling the Silent Progression of Multiple Sclerosis: Ignoring Treatments"

Silent progression, also known as progression independent of relapse activity (PIRA), is a common phenomenon in multiple sclerosis (MS) where disability worsens without experiencing relapses. A review of studies suggests that PIRA accounts for at least 50% of reported instances of disability worsening in people with relapsing-remitting MS. Additionally, factors such as medication side effects, cost, and the form of treatment (injections, infusions, or pills) can influence MS patients' adherence to their treatments. The author questions the labeling of MS stages and emphasizes the importance of considering cost when making treatment decisions.

2 years ago•Source: Multiple Sclerosis News Today

"DMT Survey, Keto Diet, and Gilenya Generic: MS News Highlights"

multiple-sclerosis

3.54 min•2 years ago

"DMT Survey, Keto Diet, and Gilenya Generic: MS News Highlights"

A survey of neurologists in the U.S. rates Kesimpta, Ocrevus, and Briumvi as the best disease-modifying therapies (DMTs) for relapsing-remitting multiple sclerosis (RRMS). The ketogenic diet has shown potential benefits for people with RRMS, including reduced body fat, improved symptoms, and increased exercise capacity, but adherence can be challenging. A real-world study in Turkey suggests that a generic version of Gilenya is safe and effective, although long-term data is needed to maintain confidence in generic MS treatments.

via Multiple Sclerosis News Today